MCO reported Q2 results on July 22 and the market's response was swift — the stock dropped nearly 3% to $490.77, pulling back from the bullish pre-earnings positioning that defined the prior two weeks. The month-long setup has partially unwound, but the underlying structure of the trade remains intact: shorts are retreating, borrow is loose, and the analyst community just raised its targets.
The earnings-day selloff did not change the lending picture. Short interest is down 21% over the past month, now at just 1.5% of free float — bears have been quietly exiting since late June, when SI ran near 2.1% of float. Borrow costs remain minimal at 0.39% annually, actually down from the mid-week highs of around 0.53%. Availability is exceptionally wide at over 3,300% — roughly 33 shares available for every one currently borrowed — meaning there is no friction in the lending market and no squeeze dynamic building. The options market has normalised post-earnings: the put/call ratio settled at 0.64, still about 1.2 standard deviations below its 20-day average of 0.74. That is less call-heavy than the 0.56 extreme reached before the print, but not yet defensive territory.
The Street's conviction held through the earnings release and into the print. JPMorgan raised its target to $600 the day before results, maintaining Overweight — the most significant recent move given the timing and the firm. Jefferies initiated last week at Buy with a $610 target, the highest on the Street. Barclays lifted to $575 earlier this month. The consensus mean target is $549.67 against a current price of $490.77, implying around 12% upside from here. The dissenters are not shouting: Morgan Stanley holds Equal-Weight with a $496 target — effectively flat to current levels — and BMO sits at Market Perform with $515. The bear case centres on potential softness in Moody's Analytics from account losses and strategic terminations, while bulls point to the MIS ratings segment's strong issuance pipeline and recurring revenue momentum. Analyst recommendation differentiation ranks in the 91st percentile across the ORTEX universe, meaning the divergence between bulls and neutral holders is unusually pronounced.
The one ownership fact worth noting is Berkshire Hathaway's anchor position at 14.1% of shares outstanding, unchanged through the March filing period. TCI Fund Management added over 1 million shares in the same quarter, lifting its stake to 8.2%. These are not fast-money holders — their presence tends to dampen volatility on large moves, which may partly explain why the earnings selloff has been contained. Insider activity from the CEO and General Counsel has followed a mechanical monthly cadence of pre-planned sales, all scored low on significance — nothing in the recent trade history suggests a change in executive conviction.
MCO's closest peer, SPGI, fell 3.8% on the same day, suggesting the weakness is sector-wide rather than company-specific. MSCI dropped a sharper 10.1% on the day and is down 8.1% on the week — a much more severe reaction that highlights MCO's relative resilience. NDAQ and ICE are modestly positive on the week, further suggesting the damage is concentrated in the pure-play financial data names exposed to credit market volumes. Whether MCO's post-earnings discount against current analyst targets narrows or widens depends on the Q2 detail around MIS issuance trends and the Analytics segment's recovery trajectory — those two lines are the scorecards the Street watches most closely.
See the live data behind this article on ORTEX.
Open MCO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
